Your browser doesn't support javascript.
loading
Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs.
Díaz-González, Álvaro; Sapena, Víctor; Boix, Loreto; Torres, Ferrán; Sanduzzi-Zamparelli, Marco; Da Fonseca, Leonardo G; LLarch, Neus; Iserte, Gemma; Guedes, Cassia; Muñoz-Martínez, Sergio; Darnell, Anna; Belmonte, Ernest; Rimola, Jordi; Forner, Alejandro; Ayuso, Carmen; Bruix, Jordi; Reig, María.
Afiliação
  • Díaz-González Á; Barcelona Clinic Liver Cancer (BCLC) Group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Sapena V; Barcelona Clinic Liver Cancer (BCLC) Group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Boix L; Barcelona Clinic Liver Cancer (BCLC) Group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Torres F; Medical Statistics Core Facility, IDIBAPS. Hospital Clínic de Barcelona. Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Sanduzzi-Zamparelli M; Barcelona Clinic Liver Cancer (BCLC) Group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Da Fonseca LG; Barcelona Clinic Liver Cancer (BCLC) Group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • LLarch N; Barcelona Clinic Liver Cancer (BCLC) Group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Iserte G; Barcelona Clinic Liver Cancer (BCLC) Group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Guedes C; Barcelona Clinic Liver Cancer (BCLC) Group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Muñoz-Martínez S; Barcelona Clinic Liver Cancer (BCLC) Group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Darnell A; Barcelona Clinic Liver Cancer (BCLC) Group. Radiology Department, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Belmonte E; Barcelona Clinic Liver Cancer (BCLC) Group. Radiology Department, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Rimola J; Barcelona Clinic Liver Cancer (BCLC) Group. Radiology Department, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Forner A; Barcelona Clinic Liver Cancer (BCLC) Group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Ayuso C; Barcelona Clinic Liver Cancer (BCLC) Group. Radiology Department, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Bruix J; Barcelona Clinic Liver Cancer (BCLC) Group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
  • Reig M; Barcelona Clinic Liver Cancer (BCLC) Group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd. University of Barcelona, Barcelona, Spain.
United European Gastroenterol J ; 9(6): 655-661, 2021 07.
Article em En | MEDLINE | ID: mdl-34228394
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Inibidores de Proteínas Quinases / Diarreia / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: United European Gastroenterol J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Inibidores de Proteínas Quinases / Diarreia / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: United European Gastroenterol J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha